institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 1 day ago • loading... • Updated 16 hours ago

Obesity medication trials look beyond the plateau to new wave of treatment options

Summary by Healthing.ca

This Story does not have an article description

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

2 Articles

All

Left

Center

Right

Mounjaro, Wegovy - the Prescription of Obesity Treatments Is Extended - News - Ufc-What to Choose

Better access to treatments or sales gains for manufacturers? Initiation of anti-obesity drugs, known as GLP-1 agonists (Wegovy/semaglutide, Mounjaro/tirzepatide, Saxenda/liraglutide) has recently opened up. By the way, expanding the number of eligible people.

16 hours ago

Read Full Article

Obesity medication trials look beyond the plateau to new wave of treatment options

1 day ago·Toronto, Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated15 hours agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Healthing.ca broke the news in Toronto, Canada 1 day ago on Friday, July 4, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read 1 out of your 5 free daily articles.